UBS Oncology Impact Fund L.P.'s Net Worth

$507 Million

Estimate Recalculated Feb 27, 2024 08:02PM EST

Who is UBS Oncology Impact Fund L.P.?

UBS Oncology Impact Fund L.P. has an estimated net worth of $507 Million. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., Cullinan Oncology, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Werewolf Therapeutics, Inc., and Oncorus, Inc..

SEC CIK

UBS Oncology Impact Fund L.P.'s CIK is 0001691428

Past Insider Trading and Trends

2020 was UBS Oncology Impact Fund L.P.'s most active year for acquiring shares with 24 total transactions. UBS Oncology Impact Fund L.P.'s most active month to acquire stocks was the month of June. 2021 was UBS Oncology Impact Fund L.P.'s most active year for disposing of shares, totalling 145 transactions. UBS Oncology Impact Fund L.P.'s most active month to dispose stocks was the month of August. 2019 saw UBS Oncology Impact Fund L.P. paying a total of $13,506,258.12 for 7,269,851 shares, this is the most they've acquired in one year. In 2022 UBS Oncology Impact Fund L.P. cashed out on 245,469 shares for a total of $10,452,333.95, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.19%
-245.47K
$42.58
-$10,452,333.95
4.48M
Jan 4 - Jan 5
Form 4
-1.73%
-83.39K
$33.73
-$2,812,427.53
4.73M
Scheduled
Dec 3 - Dec 7
Form 4
-2.82%
-139.77K
$34.47
-$4,817,417.25
4.81M
Scheduled
Nov 30 - Dec 2
Form 4
-0.77%
-38.57K
$35.18
-$1,356,824.98
4.95M
Scheduled
Nov 26 - Nov 29
Form 4
-0.95%
-145.29K
$36.85
-$4,744,666.44
15.22M
Scheduled
Nov 17 - Nov 24
Form 4
-0.55%
-28.61K
$27.45
-$785,384.39
5.14M
Scheduled
Oct 15 - Oct 18
Form 4
-1.81%
-95.00K
$27.21
-$2,584,606.09
5.17M
Scheduled
Oct 12 - Oct 14
Form 4
-1.63%
-87.01K
$27.23
-$2,368,800.16
5.26M
Scheduled
Oct 7 - Oct 11
Form 4
-0.86%
-46.13K
$27.05
-$1,247,589.54
5.35M
Scheduled
Oct 1 - Oct 4
Form 4
-0.66%
-35.99K
$27.00
-$971,730.00
5.39M
Scheduled
Sep 28 - Sep 30
Form 4
-1.62%
-89.48K
$27.76
-$2,484,093.96
5.43M
Scheduled
Sep 23 - Sep 27
Form 4
-1.02%
-56.78K
$27.50
-$1,561,393.60
5.52M
Scheduled
Sep 21 - Sep 22
Form 4
-2.67%
-152.71K
$28.38
-$4,334,451.90
5.58M
Scheduled
Sep 16 - Sep 20
Form 4
-1.32%
-76.42K
$27.70
-$2,116,733.05
5.73M
Scheduled
Sep 14 - Sep 15
Form 4
-1.63%
-96.46K
$28.32
-$2,731,459.64
5.81M
Scheduled
Sep 9 - Sep 13
Form 4
-1.71%
-102.57K
$29.03
-$2,067,786.01
5.9M
Scheduled
Sep 7 - Sep 8
Form 4
-0.00%
-200.00
$29.99
-$5,998.00
6M
Scheduled
Apr 9
Form 4
-0.95%
-57.65K
$30.99
-$1,300,850.41
6M
Scheduled
Apr 7 - Apr 8
Form 4
+64.51%
6.06M
$19.00
$6,080,000.00
15.46M
Jul 28
Form 3
0
0
No matching records found

Spring Bank Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.90%
-57.49K
$20.63
-$1,186,189.84
6.33M
Scheduled
May 28 - Jun 2
Form 4
-0.27%
-17.16K
$20.22
-$346,937.78
6.39M
Scheduled
May 26 - May 27
Form 4
-0.25%
-15.91K
$20.18
-$321,030.47
6.4M
Scheduled
May 21 - May 24
Form 4
-0.74%
-47.95K
$20.49
-$982,226.63
6.42M
Scheduled
May 18 - May 20
Form 4
-0.25%
-16.42K
$20.05
-$329,313.92
6.47M
Scheduled
May 13 - May 17
Form 4
-1.04%
-68.26K
$21.04
-$1,436,555.54
6.48M
Scheduled
May 10 - May 12
Form 4
-0.16%
-10.17K
$22.52
-$229,107.07
6.55M
Scheduled
May 5
Form 4
-4.77%
-328.52K
$22.48
-$7,386,435.35
6.56M
Scheduled
Apr 30 - May 4
Form 4
-1.85%
-130.14K
$21.99
-$2,861,368.42
6.89M
Scheduled
Apr 27 - Apr 29
Form 4
-0.13%
-8.97K
$18.97
-$170,229.38
7.02M
Scheduled
Apr 21
Form 4
-0.54%
-38.15K
$19.04
-$726,550.34
7.03M
Scheduled
Apr 16 - Apr 20
Form 4
-0.54%
-38.56K
$20.16
-$777,359.18
7.07M
Scheduled
Apr 13 - Apr 15
Form 4
-0.43%
-30.93K
$21.90
-$677,357.16
7.11M
Scheduled
Apr 9 - Apr 12
Form 4
3.9M
$11.65
-$6,258.00
3.9M
Feb 12
Form 3
0
0
No matching records found

TCR2 THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.37M
0
Jun 1
Form 4
3.37M
$15.00
3.37M
Feb 19
Form 3
0
0
No matching records found

SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.5601

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.51%
81.5K
$2.77
$226,001.00
3.33M
Nov 2 - Nov 6
Form 3
0
0
No matching records found